JUVENTAS THERAPEUTICS
Juventas Therapeutics is a privately-held clinical-stage biotechnology company developing a pipeline of regenerative therapies to treat life–threatening diseases. Founded in 2007 with an exclusive license from the Cleveland Clinic, Juventas has transitioned its therapeutic platform from concept to initiation of mid-stage clinical trials. Investors include Triathlon Medical Venture Partners, Early Stage Partners, Fletcher Spaght Ventures, Reservoir Venture Partners, North Coast Angel Fund, X Gen Ltd., JumpStart Inc., and Blue Chip Venture Co. The company has received nondilutive grant support through the Ohio Third Frontier funded Cleveland Clinic Ohio BioValidation Fund, Global Cardiovascular Innovation Center and Center for Stem Cell & Regenerative Medicine.
JUVENTAS THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Medical Medical Device Therapeutics
Founded:
2007-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.juventasinc.com
Total Employee:
11+
Status:
Active
Contact:
(216)273-4000
Email Addresses:
[email protected]
Total Funding:
48.72 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Content Delivery Network Apache Google Maps JsDelivr GoDaddy DNS GStatic Google Static Content Google Maps API
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Synnovation Therapeutics
Synnovation Therapeutics is a precision oncology company that develops therapeutics that can improve the lives of people with cancer.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Investors List
POSCO Venture Capital
POSCO Venture Capital investment in Series B - Juventas Therapeutics
Green Cross
Green Cross investment in Series B - Juventas Therapeutics
Early Stage Partners
Early Stage Partners investment in Series B - Juventas Therapeutics
North Coast Ventures
North Coast Ventures investment in Series B - Juventas Therapeutics
Triathlon Medical Venture Partners
Triathlon Medical Venture Partners investment in Series B - Juventas Therapeutics
Reservoir Venture Partners
Reservoir Venture Partners investment in Series B - Juventas Therapeutics
Venture Investors
Venture Investors investment in Series B - Juventas Therapeutics
New Science Ventures
New Science Ventures investment in Series B - Juventas Therapeutics
Takeda Ventures
Takeda Ventures investment in Series B - Juventas Therapeutics
Fletcher Spaght, Inc.
Fletcher Spaght, Inc. investment in Series B - Juventas Therapeutics
Official Site Inspections
http://www.juventasinc.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
